Scilex Holding (SCLX) Amortization of Deferred Charges (2020 - 2026)

Scilex Holding (SCLX) recorded quarterly Amortization of Deferred Charges of $1.0 million in Q1 2026, up 151.34% quarter-over-quarter from $409000.0 in Q4 2025.

Scilex Holding (SCLX) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends

Scilex Holding's Amortization of Deferred Charges history runs 6 years deep, the most recent figure standing at $1.0 million for Q1 2026.

  • In Q1 2026, Amortization of Deferred Charges changed N/A year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.4 million (up 404.21% YoY), while the FY2025 annual figure was $409000.0, up 29.43% from the prior year.
  • Amortization of Deferred Charges was $1.0 million for Q1 2026 at Scilex Holding, up from $409000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $1.9 million in Q1 2022 to a low of $1000.0 in Q2 2023.
  • Historically, Amortization of Deferred Charges has averaged $381538.5 across 5 years, with a median of $34000.0 in 2022.
  • The sharpest annual moves came in 2023 and 2024: Amortization of Deferred Charges slumped 99.92% in 2023, then surged 3100.0% in 2024.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $34000.0 in 2022, then retreated by 8.82% to $31000.0 in 2023, then soared by 616.13% to $222000.0 in 2024, then surged by 84.23% to $409000.0 in 2025, then soared by 151.34% to $1.0 million in 2026.
  • The last three Amortization of Deferred Charges figures came in at $1.0 million (Q1 2026), $409000.0 (Q4 2025), and $222000.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,026,132.38 Bn 93,026,127.42 Bn 7.76 Bn
2 Eli Lilly 1,022.62 Bn 1,017.34 Bn 16.22 Bn
3 Johnson & Johnson 570.65 Bn 548.59 Bn 15.96 Bn
4 AbbVie 398.73 Bn 389.38 Bn 10.78 Bn
5 Merck 295.53 Bn 289.88 Bn 12.09 Bn
6 Amgen 186.30 Bn 174.26 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 146.09 Bn 133.32 Bn -1.21 Bn
9 Bristol Myers Squibb 114.98 Bn 104.53 Bn 8.07 Bn
10 Scilex Holding 48.31 Mn -101.62 Mn 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.03 Mn
Mar 31, 2026 1.03 Mn
Dec 31, 2025 409,000.00
Dec 31, 2025 409,000.00
Dec 31, 2024 222,000.00
Dec 31, 2024 222,000.00
Sep 30, 2024 31,000.00
Sep 30, 2024 31,000.00
Jun 30, 2024 32,000.00
Jun 30, 2024 32,000.00
Mar 31, 2024 31,000.00
Mar 31, 2024 31,000.00
Dec 31, 2023 31,000.00
Dec 31, 2023 31,000.00
Sep 30, 2023 33,000.00
Sep 30, 2023 33,000.00
Jun 30, 2023 1,000.00
Jun 30, 2023 1,000.00
Dec 31, 2022 34,000.00
Dec 31, 2022 34,000.00